Regions Financial Corp Incyte Corp Transaction History

Regions Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$73.52 - $88.7 $882 - $1,064	-12 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$58.5 - $69.94 $46,566 - $55,672	-796 Reduced 98.51%	12 $1,000
Q3 2018 Oct 22, 2018	SELL	$61.75 - $74.23 $1.15 Million - $1.38 Million	-18,575 Reduced 95.83%	808 $56,000
Q2 2018 Jul 26, 2018	BUY	$60.85 - $83.98 $30,546 - $42,157	502 Added 2.66%	19,383 $1.3 Million
Q1 2018 Apr 18, 2018	BUY	$83.06 - $100.98 $1.57 Million - $1.91 Million	18,881 New	18,881 $1.57 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.